Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-11-25
1998-02-17
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514311, 514312, A61K 3147, A01N 4342, A01N 4354
Patent
active
057191573
ABSTRACT:
The present invention provides a pharmaceutical composition for inhibiting bone resorption or for preventing or treating osteoporosis which comprises a quinoline or quinazoine derivative as an active ingredient.
REFERENCES:
patent: 4146719 (1979-03-01), Irikura
patent: 4343940 (1982-08-01), Kreighbaum et al.
patent: 5023261 (1991-06-01), Kamijo et al.
patent: 5064833 (1991-11-01), Ife et al.
patent: 5124325 (1992-06-01), Kojima et al.
patent: 5126351 (1992-06-01), Luzzio et al.
Registry File Search Results--P067384B, pp. 47, 70, 77, 85, 102 and 179.
Result of CAS Online Search CA80(15):82872z.
Synthesis (9), 718-719, 1979.
IL Farmaco 44 (6), 555-563, 1989.
Baba Atsuo
Sohda Takashi
Taketomi Shigehisa
Geist Gary
Keys Rosalynd A.
Takeda Chemical Industries Ltd.
LandOfFree
Pharmaceutical composition containing quinoline or quinazoline d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition containing quinoline or quinazoline d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition containing quinoline or quinazoline d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784265